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Abstract: BACKGROUND To visualize and assess brain metastases on magnetic resonance imaging,
radiologists face an ever-increasing pressure to perform faster and more efficiently. The usage of maxi-
mum intensity projections (MIPs) of contrast-enhanced T1-weighed (T1ce) magnetization-prepared rapid
acquisition with gradient echo (MP-RAGE) images proposes to increase reading efficiency by increasing
lesion conspicuity while reducing in the number of images to be reviewed. AIM To assess if MIPs save
reading time and achieve the same level of diagnostic accuracy as standard 1 mm T1ce images for the
detection of brain metastases. METHODS Forty-four patients were included in this retrospective study.
Axial reformations of T1ce MP-RAGE (TR/TE = 2300/2.25 ms, resolution = 1 mm3 ) images were
analyzed and post-processed into 5 and 10 mm MIPs. Two readers evaluated the randomly assorted
images and recorded reading time. Reading time differences were analyzed using the Wilcoxon test, and
inter-reader statistics were performed using Bland-Altman plots. RESULTS About 22.5 61.2 s/study and
43.8 ± 159.9 s/study were saved using 5 and 10 mm MIPs, respectively. Combined average sensitivity
was 92.0% for 5 mm MIPs and 86.3% for 10 mm MIPs compared to standard 1 mm axial slices, with
an average rate of 0.98 and 0.57 false positives per study, respectively CONCLUSION: While 5 mm
and 10 mm T1ce MP-RAGE MIPs showed a clinical benefit in reducing reading times for evaluation of
brain metastases, they should be used in conjunction with standard 1 mm images for best sensitivity and
specificity, a practice which possibly annuls their benefit.
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Abstract (244 words) 
Background 
To visualize and assess brain metastases on MRI, radiologists face an ever-increasing 
pressure to perform faster and more efficiently. The usage of maximum intensity 
projections (MIPs) of contrast enhanced T1 weighed (T1ce) Magnetization-Prepared 
Rapid Acquisition with Gradient Echo (MP-RAGE) images proposes to increase 
reading efficiency by increasing lesion conspicuity while reducing in the number of 
images to be reviewed. 
 
Aim 
To assess if MIPs save reading time and achieve the same level of diagnostic 
accuracy as standard 1 mm T1ce images for the detection of brain metastases.  
 
Methods 
44 Patients were included in this retrospective study. Axial reformations of T1ce MP-
RAGE (TR/TE=2300/2.25ms, resolution=1 mm3) images were analysed and post-
processed into 5 mm and 10 mm MIPs. Two readers evaluated the randomly assorted 
images and recorded reading time. Reading time differences were analysed using the 
Wilcoxon test, inter-reader statistics were performed using Bland-Altman plots. 
 
Results 
22.5  61.2 seconds/study and 43.8  159.9 seconds/study were saved using 5 mm 
and 10 mm MIPs respectively. Combined average sensitivity was 92.0% for 5 mm 
MIPs and 86.3% for 10 mm MIPs compared to standard 1 mm axial slices, with an 
average rate of 0.98 and 0.57 false positives per study, respectively. 
 
Conclusion  
While 5 mm and 10 mm T1ce MP-RAGE MIPs showed a clinical benefit in reducing 
reading times for evaluation of brain metastases, they should be used in conjunction 
with standard 1mm images for best sensitivity and specificity, a practice which possibly 












Brain metastases are the most common form of intracranial tumor in the adult 
population and despite earlier cancer detection and decreasing cancer mortality, the 
incidence of brain metastases appears to be increasing [1]. MRI is the most sensitive 
imaging modality for detecting brain metastases [2], outperforming CT [3] and is 
routinely used in staging and assessing treatment response. Just as important as 
detecting lesions, however, is assessing the number of brain metastases, which 
greatly influences therapy options. Advancements in cross-sectional imaging lead to 
a treatment shift from whole-brain radiation therapy (WBRT) alone to surgical 
resection of single brain metastases combined with WBRT, resulting in a survival 
benefit and better quality of life [4–6]. Furthermore, stereotactic radiosurgery (SRS) is 
employed in cases of surgically inaccessible lesions or as an alternative to surgery 
[7,8] yet the focussed nature of both SRS and microsurgical resection of metastases 
renders these therapies susceptible to treatment failure in cases where the entire 
burden of metastasis is not visualized. To ensure that patients receive optimal therapy, 
exact lesion characterization on MRI is imperative. 
 
To visualize and assess brain lesions, radiologists face an ever-increasing pressure 
to perform faster and more efficiently- the current allotted time of 3 seconds per image 
[9] will only decrease as demands for radiological imaging increase [10]. One method 
to ensure that smaller lesions are not overlooked due to time constraints or 
visual/tedious fatigue is to increase their conspicuity. Delayed postcontrast imaging 
has been shown to visualize more metastases (one new lesion in 35.3% of cases) and 
greater volumes of metastases (25.4% mean increase in metastasis volume at 10 
mins, additional 9% at 15 mins) [11], yet authors noted difficulty in differentiating true 
tumor enhancement from leakage of contrast into the edematous areas surrounding 
the lesions. Another approach aiding radiologists is automated lesion detection; while 
early impacts of artificial intelligence in the detection of brain metastases seem 
promising [12], the only FDA approved AI-based software in neuroradiology to date 
has been limited to stroke imaging [13].  
The usage of maximum intensity projections (MIPs) of contrast enhanced T1 weighed 
images (T1ce) for the detection of brain metastases proposes to increase reading 
efficiency by increasing lesion conspicuity while reducing in the number of images to 
be reviewed; MIPs have already been shown to increase sensitivity and decrease 
reading time in the detection of pulmonary nodules on CT [14,15]. MP-RAGE (and its 
equivalents among vendors SPGR/BRAVO, TFE, 3D Fast FE)  is a well-established, 
widely used T1 weighted, gradient-echo pulse sequence [16] known for precise 
anatomical detail and high contrast between grey and white matter [17]; it has thus 
been consensus-recommended for brain tumor imaging[18]. One study evaluating 
detection of brain metastases reported a higher sensitivity using MIPs of SPGR (MP-
RAGE equivalent) compared to source images- this study did not assess reading time 
or false positives [19]. Further studies on brain metastases report time savings, high 
sensitivities and low false positive rates using MIPs of black-blood sequences[20,21]; 
these sequences, however, aren’t available on all MR systems [18]. The purpose of 
this work is to assess the clinical utility of MIPs through reading efficiency in time per 
exam and sensitivity/specificity in detecting brain metastases compared to T1ce MP-
RAGE MRI source images. The standard 1 mm T1ce images serve as the reference 
standard. 
 1.2 Materials and Methods 
 
1.2.1 Patients 
This retrospective study was approved by the institutional review board. 50 MRI 
studies (average age 60, range 31-79) were included: 46 with brain metastases (origin: 
23 pulmonary, 12 breast, 6 melanoma, 2 ovary, 3 other (cancer of unknown primary 
and sarcomas)) and 4 without brain metastases. Patients with leptomeningeal disease 
were not included in the study. Of the patients with brain metastases, 3 had a history 
of operative resection of metastases. Six studies were excluded due to motion 
artefacts. 
1.2.2 MRI 
Patients were scanned at our institution (University Hospital of Basel) on 3T and 1.5T 
magnetic resonance imaging (MRI) systems (Siemens Healthcare, Erlangen, 
Germany; 3T: Skyra, Verio, Prisma, 1.5T: Avanto, Espree) from December 2013 to 
August 2015.  Axial reformations of original native and contrast enhanced T1 weighted 
(T1 and T1ce) magnetization-prepared rapid gradient-echo (MP-RAGE, acquired 
sagitally) images were utilized for analysis and post-processing into maximum 
intensity projections (MIP). Dotarem 0.2 mL/kg (0.1 mmol/kg) body weight was 
administered to all patients. Sequence parameters were identical for native and 
contrast enhanced T1w MP-RAGE sequences: TR/TE 3T Skyra 2300/2.3ms; 3T Verio 
2000/3.3ms; 3T Prisma 1570/2.5ms; 1.5T Avanto 2700/5.0ms; 1.5T Espree 
2700/5.0ms; FOV 256 x 256 mm, matrix size 256 x 256 mm; slice thickness 1 mm. 
Post-processing into axial 5 mm (4mm overlap) and 10 mm (9mm overlap) maximum 
intensity projections (MIP) was performed using a TeraRecon 3D workstation 
(Aquarius iNtuition Viewer, Aquarius, TeraRecon, San Matteo, CA, USA). All MIPs 
were stored anonymously in the General Electric Centricity picture archiving and 
communication system (GE-PACS, General electric).  
1.2.3 Image Analysis 
Before analysis, all imaging data were anonymized. Two readers (CF and NH) with 11 
and 5 years of experience in neuroradiology evaluated axial planes of the randomly 
assorted studies (1 mm source images, 5 mm MIPs and 10 mm MIPs) individually in 
sessions of 15 studies/day with a minimum of two weeks between sessions. Readers 
were blinded to MIP thickness and other image thicknesses were not available for 
comparison to the study currently being evaluated. Readers recorded reading time 
using stopwatches. As the 1 mm slices represented the current gold standard, 
differences in lesion numbers on 1 mm slices between readers were agreed upon in 
consensus in a second reading session.  Metastases were defined as all discrete 
punctate or ring-enhancing lesions within the brain parenchyma. 
1.2.4 Statistical Analysis 
Reading times between the 1 mm slices and the 5 mm and 10 mm MIPs were 
compared using the non-parametric Wilcoxon test. Interreader correlation for the 5 mm 
and 10 mm MIPs was performed using Bland-Altman plots with regression analysis of 
the plots. Sensitivity of the differing methods was calculated after false negatives were 
established on 5 mm MIPs and 10 mm MIPs using the 1 mm slices as the gold 
standard. False positives were also established and were presented as a rate per 




Over 44 studies read, both the 5 mm and 10 mm MIPs resulted in time saved for both 
readers (Table 1: Reader 1, 5 mm MIP, 10 minutes 28 seconds saved in total, 10 mm 
MIP, 20 minutes 17 seconds saved in total; Reader 2, 5 mm MIP, 22 minutes 32 
seconds saved in total, 10 mm MIP, 43 minutes 53 seconds saved in total). Thus, the 
combined average for time saved per study was 22.5  61.2 seconds (p = 0.0001) for 
5 mm MIPs and 43.8  159.9 seconds (p = 0.006) for 10 mm MIPs. The reduction in 
reading time was significant using both 5 mm and 10 mm MIPs.  
Lesion totals for both readers were as follows (Table 2):  
1 mm, consensus 293 lesions; 5 mm MIPs: Reader 1, 294 lesions with 34 false 
positives and 33 false negatives, Reader 2: 327 lesions with 52 false positives and 18 
false negatives; 10 mm MIPs: Reader 1, 256 lesions with 21 false positives and 58 
false negatives, Reader 2: 286 lesions with 29 false positives and 36 false negatives. 
Average number of lesions/study was: 1 mm, 6.7, 5 mm MIPs,7.1, 10 mm MIPs, 6.2. 
Metastasis size distribution is as follows: 1 mm to 4 mm 140/293 (48%), 5 mm to 8 
mm 87/293 (30%), 9 mm to 12 mm 33/293 (11%), 13 mm to 16 mm 15/293 (5%), 17 
mm to 19 mm 9/293 (3%), 20 mm 9/293 (3%). 
This resulted in a combined average sensitivity of 92.0% for 5 mm MIPs and 86.3% 
for 10 mm MIPs and an average rate of 0.98 and 0.57 false positives per study, 
respectively. 
Inter-reader statistics were calculated using Bland-Altman plots (Figure 1). For 5 mm 
MIPs, regression analysis revealed no systematic differences between the two readers 
(t= 0.602, sig= 0.551). For 10 mm MIPs, regression analysis revealed a systematic 
difference (t= 2.311, sig= 0.026) which can be attributed to the different thresholds 
individual readers had in deciding if a lesion was present or not: Reader 2 accumulated 
a higher total lesion score (286 vs 256) and recorded more false positives (29 vs 21) 
but less false negatives (36 vs 58).  
 
1.4 Discussion  
 
In this study, we could show that the use of maximum intensity projections of T1ce 
MP-RAGE MRI source images alone for the evaluation of brain metastasis resulted in 
decreased reading times which was statistically significant, however lead to a higher 
number of false positives and false negatives when compared to 1mm slices. This was 
especially pronounced in the thickest MIPs used in this study (10 mm). 
Reasons for decreased sensitivity of metastases on MIPs were the thickened 
appearance of (enhancing) dural structures such as the tentorium and the dura of the 
convexities (Figure 2), especially near the vertex- this effect was noted especially for 
the smaller lesions. Furthermore, the superimposition of normally enhancing 
structures such as the pineal gland, the pituitary gland / cavernous sinus, and the 
choroid plexus essentially obscured visualization of metastases located either 
superiorly or inferiorly to these areas. In many instances where (generally bigger) 
multiple metastases were found to overlap on axial slices, it could not be determined 
on MIPs if they were two separate lesions or a multilobular single lesion. These effects 
were more pronounced on 10 mm MIPs compared to 5 mm MIP resulting in a lower 
sensitivity for 10 mm MIPs. 
Specificity was influenced by factors similar to those affecting sensitivity. First, focal 
enhancing vascular structures of the skull, such as hemangiomas, or structures along 
the dura (Figure 3) were superimposed onto the brain parenchyma near the vertex 
and basal aspects of the skull, creating the illusion of a focal enhancing parenchymal 
lesion. The averaging effect of the MIPs on the parenchyma obscured any darker 
(hypointense) parenchymal lesions such as cystic lesions or resection cavities - 
therefore, multiple enhancing lesions along the border of the cystic lesion were not 
seen as associated to one cystic lesion and recorded as separate. In these cases, the 
1 mm slices must be referred to. Due to this, the 1 mm slices should, in fact, be 
consulted for every study, negating the benefit of time saving from the MIPs. 
Interestingly, less false positives were found on 10 mm MIPs (rate 0.57 false positives 
per study) than on 5 mm MIPs (rate of 0.98 false positives per study) possibly due to 
effects also decreasing sensitivity. 
Previous studies on comparing MIPs to source images for detection of metastases on 
brain MRI report heterogeneous results. Sepulveda et al. report increased detection 
of metastases on MIPs of contrast-enhanced, T1-weighted SPGR images (equivalent 
to MPRAGE) compared to source images[19]. While this study did not assess false 
positives, they suggested that source images were better for detecting metastases 
closer to enhancing brain structures such as the choroid plexus. Bae et al. report a 
higher detectability of brain metastases and lower false positive rates using source 
images and MIPs of a black blood sequence (iMSDE-TSE) compared to source 
images and MIPs of a non-black-blood sequence (3D-GRE)[20]. Both of these studies, 
however, suggest MIPs be used together with source images for best diagnostic 
performance, effectively nullifying potential time savings. A recent study by Yoon et al. 
is the first to suggest that MIPs of another sequence with black-blood properties 
(CUBE) could replace source images altogether [21]. They admit, however, that faulty 
black-blood suppression of short-segment vascular structures and superimposition-
effects of patients with innumerable metastases represent obstacles to full 
replacement of source images. 
Limitations of the present study are: For potential sources of error, the nature of the 1 
mm axial slices compared to the 5 mm and 10 mm MIPs allowed readers to 
comprehend which image they were reading and were resultingly not fully blinded- this 
is a systematic limitation in all previously published studies comparing MIPs to source 
images. Although we didn’t exclude postoperative studies in the cohort, the artefacts, 
especially dural thickening, is another potential source of error. We felt, however, that 
including postoperative MRIs was more representative of clinical routine and in fact a 
strength of our study. Finally, no histologic data was available for determination of 
ground truth for metastases as surgical resection of multiple metastases is usually not 
performed.  
In this study, we could show that the use of maximum intensity projections of axial 
T1ce MP-RAGE MRI source images alone for the detection of brain metastasis 
detection resulted in a statistically significant decrease in reading time, however led to 
a higher number of false positive and false negative results.  
1.5 Conclusion 
 
While 5 mm and 10 mm T1ce MP-RAGE MIPs showed a clinical benefit in reducing 
reading times for evaluation of brain metastases, they should be used in conjunction 
with standard 1mm images for best sensitivity and specificity, a practice which possibly 
annuls their benefit. 
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 5 mm MIP 10 mm MIP 
Reader 1 14.3  63.4 s 27.7  112.2 s 
Reader 2 30.7  58.4 s 59.8  207.6 s 
Combined Average 22.5  61.2 s 43.8  159.9 s 






 Reader 1 Reader 2 Combined Average/Study 
1 mm 
Total Lesions  293 293 6.7  
5 mm 
Total Lesions  294 327 7.1  
False Positives  34 52 0.98  
False Negatives  33 18 Sensitivity 92.0%  
10 mm 
Total Lesions  256 286 6.2  
False Positives  21 29 0.57  
False Negatives  58 36 Sensitivity 86.3%  











Figure 2 Example of the three data sets: left 1 mm images, middle 5 mm MIPs, and right 10 mm MIPs. An ovoid lesion of the 
left middle frontal gyrus is clearly depicted on 1 mm images, at the border of the overlapping dura on 5 mm MIPs, and 




Figure 3 Example of a false positive lesion (right: 1 mm slices, left: 5 mm MIP): a seemingly punctate enhancing lesion is 
seen on the cortex of the right middle frontal gyrus on 5 mm MIPs (right). After correlation to the 1 mm images (left), this 
structure is revealed to be a focal irregularity of the dura projecting into the subarachnoid space, most likely representing a 
vascular structure. 
 
